Literature DB >> 221094

Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin: a case report with a review of the literature.

R J Vermeer, H M Pinedo.   

Abstract

Adenoid cystic carcinoma is relatively uncommon and often originates from the salivary glands. Although distant metastases develop rather frequently no satisfactory form of therapy has been reported. We achieved a partial remission with adriamycin in a patient with advanced metastases of adenoid cystic carcinoma. This case is described, and a short review of the literature, including papers on the treatment of advanced disease, is also given.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221094     DOI: 10.1002/1097-0142(197905)43:5<1604::aid-cncr2820430506>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Adenoid cystic carcinoma of the skull base.

Authors:  P R Issing; I Hemmanouil; T Stöver; H G Kempf; L Wilkens; R Heermann; T Lenarz
Journal:  Skull Base Surg       Date:  1999

2.  Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck.

Authors:  D E Mattox; D D Von Hoff; S P Balcerzak
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

3.  A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands.

Authors:  A S Jones; D E Phillips; J A Cook; T R Helliwell
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.